Service decision and evidence guide

Brazil equipment registration: compare manufacturer authorization and local evidence ownership

Anvisa’s acquired equipment instruction collection lists different document sets for different petition subjects. For its large-equipment registration example, it separates administrative/model information, an imported-device manufacturer authorization and other regulatory evidence. Use the exact petition context before appointing the local party; a registration holder in a public database is not automatically an available representative.

Evidence retrieved 2026-10-06. Source versions and topic-specific limits are listed below.

Sourced criteria · Brazil

What changes the service scope?

Decision or taskWhat the source describesWhat to prepare
Which petition subject and portfolio are actually covered?The collection’s subject 8050 example describes a large-equipment registration dossier with administrative/technical information and model/presentation details. [1]Identify the actual petition subject and product family; do not apply this example to every medical device or notification route.
What does the manufacturer authorize the local applicant to do?The imported-device example distinguishes a manufacturer declaration authorizing representation/commercialization from other regulatory documentation. [2]Check covered entities/products, original signature/legalization and language requirements against the exact current petition context.
Who owns signed and submitted evidence?The collection discusses legal/technical-responsible signatures, native digital documents and responsibility for consistency of uploaded instructions for use. [3]Name the actual applicant, legal/technical signers and document owners; agree access, version control and submission checks.
How is a manufacturer identity/address change handled?A separate change-document example describes a manufacturer declaration when the responsible imported-device manufacturer’s name/address changes. [4]Review the actual change subject and affected records before assuming the old appointment or registration covers the new facts.

These are English editorial paraphrases of a Portuguese instruction collection with no verified release date. Exact petition scope, current RDC provisions, applicant authorizations and translation require independent review. No universal local-licence, registration route, provider availability or deadline determination is made.

A scoped evidence and handoff plan

Use this checklist to gather your business or product details before speaking with a specialist. The items below explain what to record and suggest useful supporting documents. You can add your own answers in the editable project brief.

  1. Which petition subject and portfolio are actually covered?

    Identify the actual petition subject and product family; do not apply this example to every medical device or notification route.

    Useful evidence: Reviewed route/petition subject, intended-use description, portfolio and model/presentation list.

  2. What does the manufacturer authorize the local applicant to do?

    Check covered entities/products, original signature/legalization and language requirements against the exact current petition context.

    Useful evidence: Manufacturer declaration, legal entities/product scope and reviewed translation/legalization requirements.

  3. Who owns signed and submitted evidence?

    Name the actual applicant, legal/technical signers and document owners; agree access, version control and submission checks.

    Useful evidence: Signer/authority matrix, source files, labeling/IFU versions and submission/change-control process.

  4. How is a manufacturer identity/address change handled?

    Review the actual change subject and affected records before assuming the old appointment or registration covers the new facts.

    Useful evidence: Change rationale, affected registration/notification/label records and updated manufacturer authorization.

Work packages and dependencies

Questions for providers

Sources and data dates

Read the official document in context. The audit details identify the precise locators and preserved versions used for this page.

ANVISA — published reference ↗

Version not stated by the source · retrieved 2026-10-06

Audit details: precise locators and snapshot identifiers

Source key D08 · snapshot 6d72fc8ca0f9b50d4a04698e62be45e9e02fb6d75d46cd7359305f8ae507be10

  • [1] PDF page 1 · record 95c5980cff19e984b762a410c586ca008d2865ae2257ec1d8570a39e8a41c4ae
  • [2] PDF page 3 · record 0b60d5af0b106bbf57dc78ebead2abc35c9fb09f799bd2999f32f95e557835e1
  • [3] PDF page 29 · record 1038d0eba8ce384a778c6e9332b581d84e6c3b08229d60e881664305fa2e7374
  • [4] PDF page 30 · record fb0e0c559ea1d735d352fec4502528a02b2d74cb0a2cf1c4d5affc2aef18c027

Prepare an editable project brief

Confirm the facts, scope and contact preference before sharing your project. Preparing this page sends no provider outreach.

Choose work packages to discuss

Compare Find Brazil ANVISA Local Representatives | Get Quotes